Scribe Therapeutics Inc. Common Stock (SCTX) Price Prediction & ForecastSCTXScribe Therapeutics Inc. Common Stock

Alphio's SCTX stock price prediction model matches the current Scribe Therapeutics Inc. Common Stock tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.84 (+0.34%). The 1-week path is $16.95 (+1.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Scribe Therapeutics is currently trading at $15.54, which is significantly below the analyst price target of $60, indicating potential for substantial upside. However, the RSI is at 32.944, suggesting the stock is oversold, which could lead to a short-term rebound. The company has reported a gross margin of 100%, but it is facing significant net losses, with a net income of -6.48 million in Q2 2026. The main risk is the company's negative earnings per share of -0.37 and ongoing concerns about long-term profitability and market acceptance of its gene-editing platform.

Scribe Therapeutics Inc. Common Stock (SCTX) last closed at $16.7800007, gaining +3.58%. These facts feed the 1-day and 1-week SCTX price prediction above.